5.33
price down icon1.11%   -0.06
after-market After Hours: 5.40 0.07 +1.31%
loading
Abeona Therapeutics Inc stock is traded at $5.33, with a volume of 1.05M. It is down -1.11% in the last 24 hours and up +6.60% over the past month. Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
See More
Previous Close:
$5.39
Open:
$5.4
24h Volume:
1.05M
Relative Volume:
1.93
Market Cap:
$236.19M
Revenue:
-
Net Income/Loss:
$-54.19M
P/E Ratio:
-2.0659
EPS:
-2.58
Net Cash Flow:
$-37.34M
1W Performance:
+10.12%
1M Performance:
+6.60%
6M Performance:
-18.00%
1Y Performance:
+67.08%
1-Day Range:
Value
$5.225
$5.48
1-Week Range:
Value
$4.66
$5.68
52-Week Range:
Value
$3.20
$6.78

Abeona Therapeutics Inc Stock (ABEO) Company Profile

Name
Name
Abeona Therapeutics Inc
Name
Phone
646-813-4701
Name
Address
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
Name
Employee
136
Name
Twitter
@abeonabio
Name
Next Earnings Date
2024-12-11
Name
Latest SEC Filings
Name
ABEO's Discussions on Twitter

Compare ABEO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ABEO
Abeona Therapeutics Inc
5.33 236.19M 0 -54.19M -37.34M -2.58
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 125.74B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.57B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.40B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.36B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.89B 3.81B -644.79M -669.77M -6.24

Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-05-25 Initiated Oppenheimer Outperform
Jul-03-24 Initiated H.C. Wainwright Buy
May-30-24 Initiated Stifel Buy
Nov-11-20 Upgrade Cantor Fitzgerald Neutral → Overweight
Sep-18-20 Initiated B. Riley FBR Buy
Feb-10-20 Initiated SVB Leerink Outperform
Dec-10-19 Resumed Cantor Fitzgerald Neutral
Aug-15-19 Downgrade Maxim Group Buy → Hold
Aug-12-19 Downgrade Cantor Fitzgerald Overweight → Neutral
Jul-26-19 Downgrade Mizuho Buy → Neutral
Jun-27-19 Initiated Mizuho Buy
Oct-12-18 Initiated Mizuho Buy
Jun-05-18 Initiated Seaport Global Securities Buy
Nov-08-17 Initiated SunTrust Buy
Oct-16-17 Reiterated H.C. Wainwright Buy
Oct-11-17 Reiterated Cantor Fitzgerald Overweight
Oct-10-17 Initiated Citigroup Buy
Oct-05-17 Reiterated Maxim Group Buy
Sep-15-17 Initiated RBC Capital Mkts Outperform
Jul-18-17 Reiterated Maxim Group Buy
Jun-22-17 Resumed Jefferies Buy
Jan-06-17 Initiated Jefferies Buy
Sep-29-16 Reiterated Maxim Group Buy
View All

Abeona Therapeutics Inc Stock (ABEO) Latest News

pulisher
02:06 AM

Abeona Therapeutics Inc (ABEO) looking to reclaim success with recent performance - Sete News

02:06 AM
pulisher
09:25 AM

ABEO Shares Experience Surge in Value - knoxdaily.com

09:25 AM
pulisher
Apr 24, 2025

Stock Performance Spotlight: Abeona Therapeutics Inc (ABEO) Ends the Day at 5.22, Down by -1.14 - DWinneX

Apr 24, 2025
pulisher
Apr 23, 2025

Examining ABEO’s book value per share for the latest quarter - uspostnews.com

Apr 23, 2025
pulisher
Apr 23, 2025

Why Invest In Abeona Therapeutics Inc (ABEO) Stock? - Marketing Sentinel

Apr 23, 2025
pulisher
Apr 22, 2025

(ABEO) Investment Analysis and Advice - news.stocktradersdaily.com

Apr 22, 2025
pulisher
Apr 21, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 21, 2025
pulisher
Apr 21, 2025

Abeona Therapeutics: pz-cel Has Massive Potential For RDEB Patients - Seeking Alpha

Apr 21, 2025
pulisher
Apr 15, 2025

Wellington Management Group LLP Acquires Shares of 93,289 Abeona Therapeutics Inc (NASDAQ:ABEO) - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

Abeona Therapeutics: An Uncertain Pivotal Regulatory Catalyst With Limited Long-Term Upside - Seeking Alpha

Apr 14, 2025
pulisher
Apr 14, 2025

Trexquant Investment LP Invests $382,000 in Abeona Therapeutics Inc (NASDAQ:ABEO) - Defense World

Apr 14, 2025
pulisher
Apr 14, 2025

FDA Action Alert: Regeneron, Sanofi and Abeona - BioSpace

Apr 14, 2025
pulisher
Apr 12, 2025

Abeona Therapeutics: A Buy With Major PDUFA Catalyst On April 29 That Should Send Shares Higher - Seeking Alpha

Apr 12, 2025
pulisher
Apr 10, 2025

Abeona Therapeutics Inc. Rings the Nasdaq Stock Market Closing Bell - Nasdaq

Apr 10, 2025
pulisher
Apr 10, 2025

Abeona Therapeutics Inc. Rings the Closing Bell - Nasdaq

Apr 10, 2025
pulisher
Apr 08, 2025

Stifel initiates Abeona Therapeutics stock with buy, $14 target By Investing.com - Investing.com UK

Apr 08, 2025
pulisher
Apr 06, 2025

Krystal Biotech: Some Uncertainty, Some Value (NASDAQ:KRYS) - Seeking Alpha

Apr 06, 2025
pulisher
Apr 05, 2025

(ABEO) Technical Data - news.stocktradersdaily.com

Apr 05, 2025
pulisher
Apr 02, 2025

Breakeven On The Horizon For Abeona Therapeutics Inc. (NASDAQ:ABEO) - simplywall.st

Apr 02, 2025
pulisher
Apr 01, 2025

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Apr 01, 2025
pulisher
Apr 01, 2025

Abeona Therapeutics Expands Team with Strategic Stock Grants for Key New Talent - Stock Titan

Apr 01, 2025
pulisher
Mar 31, 2025

Abeona Therapeutics CEO sells shares worth $119,500 By Investing.com - Investing.com India

Mar 31, 2025
pulisher
Mar 31, 2025

Abeona Therapeutics CEO sells shares worth $119,500 - Investing.com

Mar 31, 2025
pulisher
Mar 28, 2025

What is Zacks Small Cap’s Estimate for ABEO Q3 Earnings? - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

Biotech Stocks Facing FDA Decision In April 2025 - RTTNews

Mar 27, 2025
pulisher
Mar 27, 2025

What is Zacks Small Cap’s Forecast for ABEO Q1 Earnings? - Defense World

Mar 27, 2025
pulisher
Mar 27, 2025

Equities Analysts Set Expectations for ABEO Q1 Earnings - Defense World

Mar 27, 2025
pulisher
Mar 26, 2025

Trend Tracker for (ABEO) - news.stocktradersdaily.com

Mar 26, 2025
pulisher
Mar 26, 2025

What is HC Wainwright’s Forecast for ABEO Q1 Earnings? - Defense World

Mar 26, 2025
pulisher
Mar 25, 2025

Abeona Therapeutics (NASDAQ:ABEO) Given Buy Rating at HC Wainwright - Defense World

Mar 25, 2025
pulisher
Mar 25, 2025

Abeona Therapeutics (NASDAQ:ABEO) Upgraded to Hold at StockNews.com - Defense World

Mar 25, 2025
pulisher
Mar 24, 2025

Abeona Therapeutics: Positive Outlook Amid FDA Hopes - MSN

Mar 24, 2025
pulisher
Mar 24, 2025

ABEO: Countdown to PDUFA Date of April 29, 2025… - MSN

Mar 24, 2025
pulisher
Mar 24, 2025

ABEO: Countdown to PDUFA Date of April 29, 2025 - Smartkarma

Mar 24, 2025
pulisher
Mar 22, 2025

Abeona Therapeutics Inc. (NASDAQ:ABEO) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 22, 2025
pulisher
Mar 21, 2025

Abeona planning potential US launch of pz-cel to treat RDEB - Epidermolysis Bullosa News

Mar 21, 2025
pulisher
Mar 21, 2025

Abeona Therapeutics Inc (ABEO) Q4 2024 Earnings Call Highlights: Strategic Advancements and ... - Yahoo

Mar 21, 2025
pulisher
Mar 21, 2025

Abeona Therapeutics Inc (ABEO) Q4 2024 Earnings Call Highlights: Strategic Advancements and ... By GuruFocus - Investing.com Canada

Mar 21, 2025
pulisher
Mar 21, 2025

Abeona Therapeutics Reports 2024 Financial Results - TipRanks

Mar 21, 2025
pulisher
Mar 20, 2025

Earnings call transcript: Abeona Therapeutics reports Q4 2024 EPS beat - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Earnings call transcript: Abeona Therapeutics reports Q4 2024 EPS beat By Investing.com - Investing.com UK

Mar 20, 2025
pulisher
Mar 20, 2025

Abeona Therapeutics targets $2B revenue potential for pz-cel amid U.S. launch preparations - MSN

Mar 20, 2025
pulisher
Mar 20, 2025

Oppenheimer maintains Abeona Therapeutics Outperform rating - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Abeona Therapeutics® Reports Full Year 2024 Financial - GlobeNewswire

Mar 20, 2025
pulisher
Mar 20, 2025

Abeona Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

ABEONA THERAPEUTICS INC. SEC 10-K Report - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory - Bluefield Daily Telegraph

Mar 20, 2025
pulisher
Mar 20, 2025

Abeona Strengthens to $98M Cash Position as FDA Decision for Pz-cel Approaches - StockTitan

Mar 20, 2025
pulisher
Mar 20, 2025

Abeona Therapeutics Inc (ABEO) Q4 2024 Earnings Call Highlights: Strategic Advancements and Financial Resilience - GuruFocus

Mar 20, 2025
pulisher
Mar 16, 2025

(ABEO) On The My Stocks Page - news.stocktradersdaily.com

Mar 16, 2025
pulisher
Mar 14, 2025

Abeona Therapeutics Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView

Mar 14, 2025

Abeona Therapeutics Inc Stock (ABEO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Cap:     |  Volume (24h):